RECAP: CABS Translational AI in Biomedicine Workshop

Date: June 30, 2026 @ 12:00 am –
Location: 1633 Old Bayshore Hwy #280, Burlingame, CA 94010

Translational AI in Biomedicine: From Discovery to Real-World Impact

Organizer: CABS STC | Sponsor: Innovo Health Labs, ChemScene

Overview

On May 30, 2026, the Science & Technology Committee (STC) of the Chinese American Biopharmaceutical Society (CABS) successfully organized the workshop, “Translational AI in Biomedicine: From Discovery to Real-World Impact,” with sponsorship from Innovo Health Labs and ChemScene. The event brought together leading experts from academia and industry to discuss the growing role of artificial intelligence in biomedical research and drug development.

Through presentations and discussions, participants explored how AI-driven technologies can accelerate scientific discovery, streamline translational research, and facilitate the adoption of innovative solutions in real-world healthcare settings. The workshop also examined emerging AI applications across the biomedical innovation pipeline, from early-stage discovery to clinical development, while addressing practical challenges and opportunities in implementation. By fostering interdisciplinary dialogue and collaboration, the event aimed to inspire new ideas and advance the future of AI-enabled biomedical innovation.

The workshop opened with a warm welcome and introduction of CABS by Liping Meng (President-Elect of CABS), followed by an overview of the agenda and speaker introductions by Dr. Alex Yang (Co-Chair of the STC).

Scientific Presentations

The first presentation, “AI agents to accelerate biomedical discoveries,” was delivered by Dr. James Zou (Associate Professor, Stanford University). Prof. Zou outlined that AI "Virtual Labs" can perform complex scientific research. Multiple specialized agents outperform a single general-purpose agent. Groups of agents can develop their own collaborative social dynamics, allowing them to coordinate and solve problems more efficiently.